- Reported purity
- 99.35%99.0–99.49%
- Test date
- Jul 22, 2026
- Laboratory named
- ILS Laboratories
Lot details
CB01
Loading peptide prices…
Loading peptide prices…
Compare observed vial prices, price per mg, and current indexed COA records across vendors.
Based on the certificates our crawler found; vendors may publish more than we index. Indexed documents do not establish product quality. Index as of Oct 2026.
Price-drop alert
Today’s lowest in-stock price is $0.75/mg. We check daily and email you once if it drops 10% or more. The alert ends after that, or after six months.
Some outbound vendor links are affiliate links. Commission status does not change the displayed prices, indexed COA fields, or certificate filters.
Observed market data
Based on the certificates our crawler found; vendors may publish more than we index.
Observed Cerebrolysin listings span $45-$199 in total vial price, with a median of $0.99 per mg across 20 usable listings as of Oct 14, 2026. Compare observed Cerebrolysin listings by vial size, total price, price per mg, stock status, and last-checked date. This research-market view does not recommend a seller or verify a product for clinical use. Each vendor row shows its current COA record, including the reported purity, named lab, and printed test date.
Observed Cerebrolysin listings span $45-$199 in total vial price, with a median of $0.99 per mg across 20 usable listings as of Oct 14, 2026.
The comparison covers observed vial prices, price per mg, vial sizes, stock signals, vendor coverage, and last-checked dates. It does not verify product quality or recommend a seller.
The index holds 2 public Cerebrolysin certificates of analysis. We found certificates from a few of the Cerebrolysin vendors we track. Based on the certificates our crawler found; vendors may publish more than we index.
Choose “Highest COA purity” to sort vendors by the value printed on each current certificate. The number belongs to that document, lab, lot, and test date. It cannot establish product quality or safety, and values from different labs or methods are not directly comparable.
Product documentation
We found certificates from a few of the Cerebrolysin vendors we track. The public evidence set contains 2 documents naming 2 laboratories. Reported test dates in this set run from Jan 13, 2026 through Jul 22, 2026.
Based on the certificates our crawler found; vendors may publish more than we index.
2 current records
CB01
CER25-30-001
| Printed lab | Certificate | |||
|---|---|---|---|---|
| Disguised Alpha | ILS Laboratories | Jul 22, 2026 | 99.35%99.0–99.49% | View COA |
| nuscience | Chromate | Jan 13, 2026 | No purity printed | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
Lab, lot, date, compound, and purity fields are transcribed from the document and can contain extraction errors. “Older record” means the reported test date is more than 18 months old.
Learn how to read a peptide COA or review the testing methodology and dataset.
The clinic network
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves